Abstract
Objective
To investigate psychological distress, serum levels of monoamine neurotransmitters and their metabolites, as well as their correlation with polycystic ovarian syndrome (PCOS).
Methods
Thirty infertility patients with PCOS were assigned as the experimental group and 30 infertility patients without PCOS were assigned as the control group. Psychological distress was self-evaluated in all patients with Symptom Checklist 90 (SCL-90). Serum concentrations of norepinephrine (NE) and its metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxytryptamine (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA), dopamine (DA) and its metabolites homovanillic acid (HVA) and dihydroxy-phenyl acetic acid (DOPAC) were measured by high-performance liquid chromatography.
Results
The anxious and depressive subscales of SCL-90 were significantly higher in infertility patients with PCOS than those without PCOS (p < 0.05). The serum concentrations of 5-HT, 5-HIAA and HVA were significantly lower in infertility patients with PCOS than those without PCOS (p < 0.05). Importantly, the phobia subscale scores of SCL-90 positively correlated with serum MHPG level (p < 0.05), while the hostility subscale’s scores negatively correlated with serum DOPAC level (p < 0.05).
Conclusion
Psychological and neurological factors play a crucial role in PCOS.
Similar content being viewed by others
References
Balen A, Michelmore K (2002) What is polycystic ovary syndrome? Are national views important? Hum Reprod 17:2219–2227
Jones GL, Balen AH, Ledger WL (2008) Health-related quality of life in PCOS and related infertility: how can we assess this? Hum Fertil (Camb) 11:173–185
Doi SA, Towers PA, Scott CJ, Al-Shoumer KA (2005) PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod Biol 118:4–16
Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41
Blank SK, Helm KD, McCartney CR, Marshall JC (2008) Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci 1135:76–84
Legro RS, Castracane VD, Kauffman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59:141–154
Murdoch AP, Dunlop W, Kendall-Taylor P, Watson MJ (1984) The acute effects of a dopamine antagonist (domperidone) on luteinising hormone, follicule stimulating hormone, prolactin and thyrotrophin secretion in polycystic ovarian syndrome: differential effect of ovulation. Clin Endocrinol (Oxf) 21:611–619
Moro C, Pasarica M, Elkind-Hirsch K, Redman LM (2009) Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:2579–2586
Eyvazzadeh AD, Pennington KP, Pop-Busui R, Sowers M, Zubieta JK, Smith YR (2009) The role of the endogenous opioid system in polycystic ovary syndrome. Fertil Steril 92:1–12
Deeks AA, Gibson-Helm ME, Teede HJ (2010) Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 93:2421–2423
Himelein MJ, Thatcher SS (2006) Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 61:723–732
Elsenbruch S, Benson S, Hahn S, Tan S, Mann K, Pleger K, Kimmig R, Janssen OE (2006) Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod 21:1092–1099
Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, Janssen OE (2003) Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:5801–5807
Deeks AA, Gibson-Helm ME, Teede HJ (2010) Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 93:2421–2423
Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacol Bull 9:13–28
Mc Cook JG, Reame NE, Thatcher SS (2005) Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 34:12–20
Coffey S, Mason H (2003) The effect of polycystic ovary syndrome on health related quality of life. Gynecol Endocrinol 17:379–386
Dokras A, Clifton S, Futterweit W, Wild R (2011) Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 117:145–152
Elsenbruch S, Hahn S, Kowalsky D et al (2003) Quality of life, psychosocial well being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:5801–5807
Wang Y, Cao Y, Chong L et al (2005) Polycystic ovary syndrome and psychological analysis of the investigation. Anhui Med Univ (in Chinese) 40:277–279
Herbison AE (1997) Noradrenergic regulation of cyclic GnRH secretion. Rev Reprod 2:1–6
Yoshino K, Takahashi K, Eda Y, Nishigaki A, Kitao M (1991) Peripheral catecholamine metabolites and free testosterone in patients with polycystic ovary syndrome. Nippon Sanka Fujinka Gakkai Zasshi 43:351–354
Barontini M, García-Rudaz MC, Veldhuis JD (2001) Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome. Arch Med Res 32:544–552
Hernandez I, Parra A, Mendez I et al (2000) Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch Med Res 31:216–222
Ramirez VD, Dluzen DE (1987) Release of luteinizing hormone-releasing hormone (LHRH) and neuroactive substances in unanesthetized animals as estimated with push-pull cannulae (PPC). Biol Reprod 36:59–76
Wang J, Ouyang D, Ke J et al (2005) Neurotransmitter NA, 5-HT levels in hippocampus and content changes of GnRH in hypothalamus in female rats exposed to psychologic stress. Chinese J Gerontology (In Chinese) 25:673–674
Lobo RA, Granger LR, Paul WL et al (1983) Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol 145:496–503
Gill SS, Pulido OM (2001) Glutamate receptors in peripheral tissues: current knowledge, future research, and implications for toxicology. Toxicol Pathol 29:208–223
Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H (2002) GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 213:1–47
de Groat WC (2006) Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 147:S25–S40
Roth BL, Chuang DM (1987) Multiple mechanisms of serotonergic signal transduction. Life Sci 41:1051–1064
Hafkenscheid A (1993) Psychometric evaluation of the symptom checklist (SCL-90) in psychiatric inpatients. Pers Individ Differ 14:751–756
Clark A, Friedman MJ (1983) Factor structure and discriminant validity of the SCL-90 in a veteran psychiatric population. J Pers Assess 47:396–404
Cyr JJ, McKenna-Foley JM, Peacock E (1985) Factor structure of the SCL-90-R: is there one? J Pers Assess 49:571–578
Grabill K, Merlo L, Duke D, Harford KL, Keeley ML, Geffken GR, Storch EA (2008) Assessment of obsessive–compulsive disorder: a review. J Anxiety Disord 22:1–17
Ganellen RJ (2007) Assessing normal and abnormal personality functioning: strengths and weaknesses of self-report, observer, and performance-based methods. J Pers Assess 89:30–40
Conflict of interest
All of the authors have declared no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shi, X., Zhang, L., Fu, S. et al. Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome. Arch Gynecol Obstet 284, 773–778 (2011). https://doi.org/10.1007/s00404-011-1947-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-011-1947-1